Delivery Order SPE2DB22D1202-SPE2DB24FUVZ5
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to supply the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract, valued at $37,165.78, has a firm fixed price and is scheduled for completion by September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,860.27 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 200 mg/1.14 ml pens. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Dupixent 300 mg/2 ml pens. The $6,652.64 contract has a performance period through March 18, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and serves as a key pharmaceutical and medical supply provider to the Department of Defense...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Dupixent 300 mg/2 ml pens. This $20,159.69 contract has an ultimate completion date of March 29, 2024 and is not set aside for any specific business size or type. AmerisourceBergen Drug Corp is the prime contractor and serves as a pharmaceutical and medical supply provider to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,507.37 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. This order is for the supply of the specialty pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of March 19, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $60,934.22 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $14,117.12 contract is for the supply of Dupixent 300 mg/2 ml pen medication. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,914.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Dupixent 300 mg/2 ml pen 2 ml. The $3,304.72 contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA, which serves as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 300 mg/2 ml pens. The $7,857.78 contract has an ultimate completion date of April 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, with its corporate office located in Conshohocken, Pennsylvania. This award is part of a larger $999,999,999.00...